Thursday, June 20, 2019
wellness India Expo
Home Tags Biosimilars

Tag: Biosimilars

Riding on biologics wave, Biocon registers two fold growth during FY...

For the fiscal year ended March 2019, the Biocon's net profit rose over two-fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18. Company registered 64% growth in Q4 of FY19, earning 214 cr in net profits.................

ICT Mumbai to hold 3 day long ‘Biosimilar Workshop 2018’ next...

The Institute of Chemical Technology, Matunga, Mumbai is organizing a biosimilars workshop during 29th November and 1st December to educate the participants on various techniques and know-hows related to making of these fascinating drugs and the biopharma industry...………...…...

Aurobindo Pharma acquires Sandoz’s dermatology, oral solid business in US for...

Agreement comprises the Sandoz US generic oral solids and Sandoz US dermatology businesses with approximately 300 products and H1 2018 sales of USD 0.6 billion. Transaction supports the Sandoz strategy of focusing on complex generics, value-added medicines and biosimilars...……..

ICT Mumbai set to host 5 day workshop on biosimilars characterization

Supported by the BIRAC, the workshop focused on learning of techniques for characterization of biosimilars/biologics will be held from December 11th to 15th at the Institute of Chemical Technology, Mumbai.............

Biocon & Mylan’s proposed biosimilar ‘Trastuzumab’ gets USFDA nod

The US-FDA Oncologic Drugs Advisory Committee has unanimously recommended approval of Mylan and Biocon’s proposed cancer targeting biosimilar, Trastuzumab.............

Sun Pharma partners with NIV to test phytopharma drugs for Zika,...

The phytopharmaceuticals are being developed for treating individuals infected with Zika virus and possibly for curing Zika disease......

India’s quest to become a global biotech hub by 2025!

The BioVoice News takes you through the opinions of top policymakers on the preparations to transform Indian biotech industry into a giant hub in next crucial eight years..........

Wave 2 biosimilars to dominate development pipelines and approvals

The naming of biologicals and interchangability of biosimilars continue to be hotly debated topics, writes Dr Charu Manaktala.........Click to Read More

PM Modi bats for generic drugs

The Prime Minister, Narendra Modi made it clear that his government will ensure that the doctors prescribe only generic medicines to the patients.........

BioVoice eMag April 2017 Issue-11 Volume-1

BioVoice eMag April 2017 Issue-11 Volume-1: The ‘April 2017’ issue of BioVoice eMagazine includes the COVER STORY on Biorevolution 2.0: India’s quest to become a biotech...